Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

0.6024
Delayed Data
As of Jul 22
 +0.006 / +1.01%
Today’s Change
0.55
Today|||52-Week Range
3.66
-77.27%
Year-to-Date
Varian (VAR): What's in Store for the Stock in Q3 Earnings?
Jul 22 / Zacks.com - Paid Partner Content
Merck KGaA's Multiple Sclerosis Drug under Review in EU
Jul 19 / Zacks.com - Paid Partner Content
C.R. Bard (BCR) Well Poised to Beat Q2 Earnings Estimates?
Jul 21 / Zacks.com - Paid Partner Content
Evoke (EVOK) Stock Down on Poor Phase III EVK-001 Data
Jul 19 / Zacks.com - Paid Partner Content
Can CryoLife (CRY) Earnings Spring a Surprise in Q2?
Jul 21 / Zacks.com - Paid Partner Content
athenahealth (ATHN) Q2 Earnings: What's in the Cards?
Jul 18 / Zacks.com - Paid Partner Content
CytRx (CYTR) Is in Oversold Territory: What's Next?
Jul 20 / Zacks.com - Paid Partner Content
Adeptus Health (ADPT) Q2 Earnings: Will it Beat Estimates?
Jul 18 / Zacks.com - Paid Partner Content
Sarepta (SRPT) Posts Y/Y Wider Q2 Loss, Eteplirsen in Focus
Jul 20 / Zacks.com - Paid Partner Content
St. Jude Medical (STJ) Q2 Earnings: What's in the Cards?
Jul 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close0.60
Today’s open0.60
Day’s range0.59 - 0.63
Volume2,921,939
Average volume (3 months)1,812,589
Market cap$57.3M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-76.36%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,602.80
Price/Book0.91

Competitors

 Today’s
change
Today’s
% change
CRMDCorMedix Inc-0.05-3.14%
PLXProtalix Biotherapeu...-0.01-1.48%
VSTMVerastem Inc-0.01-0.76%
FATEFate Therapeutics In...+0.03+2.10%
Data as of 4:02pm ET, 07/22/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$100.0K
Annual profit (last year)-$58.6M
Net profit margin-58,587.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Steven A. Kriegsman
Chief Financial Officer &
Treasurer
John Y. Caloz
Corporate headquarters
Los Angeles, California

Forecasts

Partner Offers

Search for Jobs